Compositions for treating and inhibiting gastric and duodenal ul

Details Compositions for treating and inhibiting gastric and duodenal ul Compositions for treating and inhibiting gastric and duodenal ul

1995-06-05

1997-04-15

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 42, 514 54, 514 58, 514 61, 514925, 514926, 514927, A61K 31715

Patent

active

056209649

ABSTRACT:
A composition for treating and/or inhibiting gastric and duodenal ulcers, comprising an oligosaccharide selected from the group consisting of Formula I ##STR1## or a mixture thereof; wherein:

REFERENCES:
patent: 4935406 (1990-06-01), Colmena et al.
patent: 4938967 (1990-07-01), Newton et al.
patent: 5318780 (1994-06-01), Viegas et al.
Boren et al., Science, vol. 262, 1892-1895 17 Dec. 1993.
Evans et al., Journal of Bacteriology, Feb. 1993, pp. 674-683, vol. 15, No. 3.
Saitoh et al., Federation of European Biochemical Societies, May 1991, vol. 282, No. 2 385-387.
Lingwood, et al., Infection and Immunity, Jul. 1993, pp. 2474-2478, vol. 61, No. 6.
Fauchere, et al., Microbial Pathogenesis 1990: 9: 427-439.
Lingwood, et al., Infection and Immunity, Jun. 1992, pp. 2470-2474, vol. 60, No. 6.
Robinson, et al., J. Med. Microbiol., vol. 33 (1990). 277-284, 1990 The Pathological Society of Great Britain and Ireland.
Figueroa, et al., Journal of Infection (1992) 24,263-267.
Talley, et al., Journal of the National Cancer Institute (1991) 83, 1734-1739.
Wotherspoon, et al., The Lancet, vol. 342, Sep. 4, 1993, pp. 575-577.
Russell, et al., The Lancet, vol. 342, Sep. 4, 1993, pp. 571-574.
National Institutes of Health, Concensus Development Conference Statement, Helicobacter pylori in Peptic Ulcer Disease, Feb. 7-9, 1994, 19 pages.
Falk, et al., Proc. Natl. Acad. Sci, USA, vol. 90 pp. 2035-2039, Mar. 1993.
Huang, et al., Journal of General Microbiology (1992), 138, 1503-1513.
Koybayashi et al., Infection and Immunity, Oct. 1993, pp. 4058-4063. vol. 61, No. 10.
Clyde, et al., Infection and Immunity, Oct. 1993, pp. 4058-4063, vol. 61, No. 10.
Podolsky, J. of Biological Chemistry vol. 260, No. 14, pp. 8262-8271.
Evans, et al., Infection and Immunity(1988) 56: 2896-2906.
Evans, et al., Infection and Immunity(1989) 57: 2272-2278.
Lingwood, et al., The Lancet(1989) 2: 238-241.
Tzouvelekis, et al., Infection and Immunity(1991) 59:4252-4254.
Lambert, Reviews of Infectious Diseases(1991) 13 (Suppl.8):S691-5.
Dunn, et al., Reviews of Infectious Diseases(1991) 13 (Suppl.8):S657-64.
Hayes et al, J. Biological Chemistry, 254 (18):8777-8780, (1979).
Mizuochi et al, J. Biological Chemistry, 255(8):3526-3531, (1980).
Kessler et al, J. Biological Chemistry, 254(16):7909-7914, (1979).
Spiro et al, J. Biological Chemistry, 249(18):5704-5717, (1974).
Pelczar et al, Elements of Microbiology, McGraw-Hill Book Company:New York, 1981, pp. 222-223.

Affiliated with

Also associated with

Rating

Compositions for treating and inhibiting gastric and duodenal ul does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions for treating and inhibiting gastric and duodenal ul, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for treating and inhibiting gastric and duodenal ul will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-360828